Journal article icon

Journal article

Single dose oral sulindac for acute postoperative pain in adults.

Abstract:

BACKGROUND: Sulindac is a non-steroidal anti-inflammatory drug (NSAID) licensed for use in rheumatic disease and other musculoskeletal disorders in the UK, and widely available in other countries worldwide. This review sought to evaluate the efficacy and safety of oral sulindac in acute postoperative pain, using clinical studies of patients with established pain, and with outcomes measured primarily over 6 hours using standard methods. This type of study has been used for many decades to esta...

Expand abstract

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Neuroscience
McQuay, HJ More by this author
Journal:
The Cochrane database of systematic reviews
Issue:
4
Pages:
CD007540
Publication date:
2009
DOI:
EISSN:
1469-493X
URN:
uuid:e015f6f1-a28c-4a02-b9b0-a7303a57aca5
Source identifiers:
242032
Local pid:
pubs:242032

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP